INTRODUCTION
============

Pulmonary hypertension (PHTN) is a rare and devastating disease characterized by progressive increases in pulmonary arterial pressure and pulmonary vascular resistance which eventually leads to right ventricular failure and death ([@b2-jer-13-2-214]; [@b5-jer-13-2-214]). It may due to various etiologies such as left heart disease, parenchymal lung disease, chronic thromboembolic disease, hematologic disorders or it may be idiopathic in nature though the clinical picture of these patients is similar ([@b13-jer-13-2-214]). Patients with and advanced lung disease such as PHTN face symptomatology consistent with oxygen deprivation, including dyspnea, fatigue and exercise intolerance. Pulmonary rehabilitation (PR) in patients with PHTN patients is in fact important in the management as it improves outcomes ([@b12-jer-13-2-214]). This study is aimed at determining the effectiveness of structured PR program on exercise capacity in a population of PHTN patients.

MATERIALS AND METHODS
=====================

Study population and design
---------------------------

We conducted a retrospective review of data collected on 18 patients with diagnosis of PHTN who participated in the Northwell Health PR program. For the purposes of the study PHTN was defined in accordance to the most updated guidelines of the American College of Chest Physicians and the European Respiratory Society ([@b6-jer-13-2-214]). PHTN was defined hemodynamically as a mean resting pulmonary artery pressure greater than or equal 25 mmHg and pulmonary arterial hypertension (PAH) was a pulmonary artery wedge pressure less than or equal to 15 mmHg on right heart catheterization ([@b6-jer-13-2-214]). As the World Health Organization (WHO) has proposed a classification system for PHTN based on common clinical features and etiology which has been outlined in [Table 1](#t1-jer-13-2-214){ref-type="table"} ([@b13-jer-13-2-214]). Our patients were categorized into WHO groups of PHTN based on underlying etiology of PHTN and completed a standardized 12-week PR program to be considered for the study.

Pulmonary rehabilitation
------------------------

All patients considered for the study completed our PR program. The PR program at our center has been certified by the American Association of Cardiovascular and Pulmonary Rehabilitation and is designed towards adult patients with chronic lung disease or patients preparing/recovering from lung surgery. The program consists of an exercise and education component with three sessions weekly over a period of 12-week period. Following the completion of the 12-week program, maintenance sessions are also available for patients to participate.

The rehab facility at our site is equipped with exercise equipment such as treadmill, upper/lower body recumbent stepper (NuStep LLC, Ann Arbor, MI, USA), arm ergometers and free weights. In addition, safety equipments available include: electrocardiogram monitoring, pulse oximetry, blood pressure monitoring and supplemental oxygen. The education component consists of biweekly educational lecture series that comprise of breathing techniques along with stress and relaxation exercises. As part of our PR program all patients are asked to fill out quality of life, fatigue and sleep questionnaires before and after completion of the program.

At the time of the enrollment in PR, all patients were clinically stable, and all were receiving optimal medical therapy. Patients' baseline exercise tolerance was recorded as speed attainable on a treadmill in miles per hour (mph) and duration of exercise in minutes (min). Demographics, age, sex, New York Heart Association functional class and oxygen use were obtained from chart review. Data were analyzed using SAS ver. 9.3 (SAS Institute Inc., Cary, NC, USA). The change in each component of the treadmill exercise (speed, grade, duration), was examined using the Wilcoxon signed rank test. Improvement was defined as an increase in speed or duration (or both), with no decrease in either component). The percent of subjects who improved based on this definition was then calculated, along with the associated exact binomial 95% confidence interval. Northwell Health System Institutional Review Board approval was obtained for this study (approval number: 14-574).

RESULTS
=======

Eighteen patients with PHTN met the criteria for the study. There were a total of 5 male and 13 female patients with a mean age 67.7±11.6 years. Of these patients there were six (33.33% who were considered WHO group 1 PAH), eight WHO group III PHTN (44.44%), two WHO group IV, and two WHO V PHTN (11.11%). Demographics have been outlined in [Table 1](#t1-jer-13-2-214){ref-type="table"}. Of these patients, 14 (82.4%) were on supplemental oxygen. It was found that as a whole across all WHO groups of PHTN, treadmill speed improved following rehab (*P*\<0.0001, Wilcoxon signed rank test). Median treadmill speed prior to rehab was 1.3 mph (interquartile range \[IQR\], 1.0--1.8 mph) and 2.2 mph (IQR, 1.3--2.8 mph) following rehab [Fig. 1](#f1-jer-13-2-214){ref-type="fig"}.

Prior to rehab, median exercise time was 27 min (IQR, 22--30 min), after rehab, median exercise time was 30 min (IQR, 24--30 min). The total exercise time also improved though not found to be statistically significant. Sixteen of the 18 participants improved (88.9%; 95% exact binomial confidence interval, 65.3%--98.6%).

DISCUSSION
==========

PHTN treatment is centered on improved cardiopulmonary hemodynamics resulting in increased exercise tolerance as generally measured by the 6-min walk test. This emerging data has been seen specifically in the WHO group I PAH ([@b1-jer-13-2-214]; [@b4-jer-13-2-214]). Our study shows exercise tolerance improvements in terms of speed in mph and increased duration of exercise across multiple etiologies of PHTN after a course of structured PR. The results of this study also demonstrate that despite diagnostic etiology of PHTN and disease severity structured PR increases exercise tolerance.

The American Thoracic Society and the European Respiratory Society have defined pulmonary rehabilitation as an "evidence based, multidisciplinary and comprehensive intervention for patient with chronic respiratory diseases who are symptomatic and often have decreased daily life activities" ([@b9-jer-13-2-214]). The principal purpose of PR programs is to improve function, disease related symptoms, optimize functional capacity and an overall improvement in quality of life.

The use PR as an adjuvant to pharmacotherapy is well established ([@b9-jer-13-2-214]). PR has become a staple of therapy in advanced lung disease including chronic obstructive pulmonary disease ([@b3-jer-13-2-214]), idiopathic pulmonary fibrosis ([@b11-jer-13-2-214]) and PHTN ([@b8-jer-13-2-214]) amongst others. Early thought process of exercise in PHTN was that it may be harmful, expedite the disease process and may even cause sudden death. However, evidenced based medicine has proven the opposite to be true ([@b12-jer-13-2-214]). The underlying mechanism of PR resulting in an increased exercise tolerance remains conjectural. Disease mechanism in PHTN heavily involves endothelin-1 (ET-1), the human body's most potent vasoconstrictor. Studies have shown that chronic exercise causes an increase in the production of nitric oxide, a potent vasodilator and a decrease in the production of ET-1 which in turn may net a vasodilatory effect thereby decreasing pulmonary vascular resistances, increasing cardiac output and increasing exercise tolerance ([@b7-jer-13-2-214]). It is also important to note that the overall increase of speed in our pulmonary rehab patients points to an increase in exercise tolerance and endurance. Patients who were unable to increase their overall speed showed an increase in the duration of time there were able to exercise also pointing to an increased in endurance. A study by [@b10-jer-13-2-214] showed that ET-1 concentrations were lower in individuals who participated in strength or endurance training as compared to sedentary controls. As the knowledge and beneficial evidence of PR steadily increases the use in PHTN patients should continue to become part of standard of care.

In conclusion our study was able to show that patients with all types of PHTN and varying WHO functional class show improvement as measured by speed and time from a structured PR program. All PHTN patients should be enrolled in PR programs as part of their management in adjuvant to their pharmacotherapy and regardless of their WHO functional class.
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###### 

Patient demographics (n=18)

  Demographic            Value
  ---------------------- -----------
  Age (yr)               67.7±11.6
                         
  Sex                    
   Male                  5 (27.8)
   Female                13 (72.2)
                         
  WHO groups             
   I                     6 (33.3)
   II                    0 (0)
   III                   8 (44.4)
   IV                    2 (11.1)
   V                     2 (11.1)
                         
  WHO functional class   
   I                     1 (5.6)
   II                    7 (38.9)
   III                   9 (50.0)
   IV                    1 (5.6)

Values are presented as mean±standard deviation or number (%).

WHO, World Health Organization.
